US · Healthcare · Medical Devices
EPS came in at -0.07 against a street estimate of -0.06 — a miss of 16.7%.
Analysts rate Apyx Medical Inc a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $6.50.
| Fund | Stake |
|---|---|
| Nantahala Capital Management, LLC | 15.53% |
| Royce & Associates, LP | 7.77% |
| Archon Capital Management LLC | 6.28% |
| Vanguard Capital Management, LLC | 3.64% |
| Essex Investment Management Company, LLC | 2.70% |
| AIGH Capital Management, LLC | 2.68% |
| Silverberg Bernstein Capital Management LLC | 2.47% |
| Commonwealth Equity Services, LLC | 1.54% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Apyx Medical Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.